GNA13 and neoplasm: On the 21st day after inoculation, the tumor volume in the sh‐GNA13 group was decreased compared with that in the shRNA‐con group; the tumor volume in the GNA13 group was larger than that in the vector group, and no tumor volume differences were found between the shRNA‐con and vector groups (Figure 5A).